Y Combinator
@ycombinator
We help founders make something people want. Subscribe to our newsletter: yc.link/newsletter
ID: 113130846
http://ycombinator.com 10-02-2010 20:20:37
18,18K Tweet
1,4M Takipçi
336 Takip Edilen
AbbVie is acquiring YC S20 alum Gilgamesh Pharma’s psychedelic drug bretisilocin for up to $1.2B after it showed a 94% remission rate in Phase 2 trials for major depressive disorder. A big step toward new treatments in psychiatry. Congrats to the team! fiercebiotech.com/biotech/abbvie…